Legal & General Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.02M | Buy |
|
|||||
|
2025
Q1 | $13.3M | Buy |
|
|||||
|
2024
Q4 | $18.4M | Buy |
|
|||||
|
2024
Q3 | $17.8M | Buy |
|
|||||
|
2024
Q2 | $22M | Buy |
|
|||||
|
2024
Q1 | $11.5M | Buy |
|
|||||
|
2023
Q4 | $8.5M | Sell |
|
|||||
|
2023
Q3 | $11.2M | Buy |
|
|||||
|
2023
Q2 | $10.4M | Sell |
|
|||||
|
2023
Q1 | $13.8M | Buy |
|
|||||
|
2022
Q4 | $10.5M | Buy |
|
|||||
|
2022
Q3 | $8.62M | Sell |
|
|||||
|
2022
Q2 | $6.89M | Buy |
|
|||||
|
2022
Q1 | $7.18M | Buy |
|
|||||
|
2021
Q4 | $7.84M | Buy |
|
|||||
|
2021
Q3 | $7.97M | Sell |
|
|||||
|
2021
Q2 | $17.6M | Sell |
|
|||||
|
2021
Q1 | $30.8M | Buy |
|
|||||
|
2020
Q4 | $69.3M | Sell |
|
|||||
|
2020
Q3 | $57.4M | Buy |
|
|||||
|
2020
Q2 | $42.1M | Buy |
|
|||||
|
2020
Q1 | $24.6M | Buy |
|
|||||
|
2019
Q4 | $29.7M | Buy |
|
|||||
|
2019
Q3 | $13.5M | Buy |
|
|||||
|
2019
Q2 | $5.92M | Buy |
|
|||||
|
2019
Q1 | $4.46M | Buy |
|
|||||
|
2018
Q4 | $3.83M | Buy |
|
|||||
|
2018
Q3 | $4.72M | Buy |
|
|||||
|
2018
Q2 | $3.72M | Buy |
|
|||||
|
2018
Q1 | $1.86M | Sell |
|
|||||
|
2017
Q4 | $1.47M | Buy |
|
|||||
|
2017
Q3 | $1.12M | Buy |
|
|||||
|
2017
Q2 | $593K | Buy |
|
|||||
|
2017
Q1 | $498K | Sell |
|
|||||
|
2016
Q4 | $471K | Buy |
|
|||||
|
2016
Q3 | $567K | Buy |
|
|||||
|
2016
Q2 | $132K | Hold |
|
|||||
|
2016
Q1 | $144K | Sell |
|
|||||
|
2015
Q4 | $288K | Hold |
|
|||||
|
2015
Q3 | $231K | Hold |
|
|||||
|
2015
Q2 | $215K | Buy |
|
|||||
|
2015
Q1 | $82K | Hold |
|
|||||
|
2014
Q4 | $87K | Hold |
|
|||||
|
2014
Q3 | $126K | Buy |
|